Swiss National Bank’s Enfusion, Inc. ENFN Stock Holding History

Swiss National Bank’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-82,600	Closed	-$921K	–	2413
2025 Q1	$921K	Buy	82,600 +1,800	+2%	+$19.9K	﹤0.01%	2167
2024 Q4	$832K	Hold	80,800	–	–	﹤0.01%	2284
2024 Q3	$767K	Buy	80,800 +11,100	+16%	+$95.8K	﹤0.01%	2325
2024 Q2	$594K	Hold	69,700	–	–	﹤0.01%	2380
2024 Q1	$645K	Buy	69,700 +11,600	+20%	+$102K	﹤0.01%	2399
2023 Q4	$564K	Buy	58,100 +8,600	+17%	+$80.3K	﹤0.01%	2451
2023 Q3	$444K	Buy	49,500 +17,700	+56%	+$168K	﹤0.01%	2531
2023 Q2	$357K	Sell	31,800 -5,500	-15%	-$48.8K	﹤0.01%	2585
2023 Q1	$392K	Sell	37,300 -3,100	-8%	-$34.2K	﹤0.01%	2577
2022 Q4	$391K	Buy	40,400 +1,700	+4%	+$19.1K	﹤0.01%	2615
2022 Q3	$478K	Hold	38,700	–	–	﹤0.01%	2586
2022 Q2	$395K	Buy	+38,700	New	+$428K	﹤0.01%	2666

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Swiss National Bank's ENFN Position: Q2 2025 in Review

Swiss National Bank sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 82,600 shares — an estimated $921K sold.

Swiss National Bank first reported a position in ENFN in Q2 2022 and held it in 12 quarters. The position peaked at $921K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Swiss National Bank reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Swiss National Bank sold 82,600 Enfusion, Inc. shares in Q2 2025, an estimated $921K.
Swiss National Bank first reported a position in Enfusion, Inc. in Q2 2022 and held it in 12 quarters.
Swiss National Bank's Enfusion, Inc. position peaked at $921K in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.